Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1992 of 5804
-
New PET tracer aims to reveal hidden heart nerve damage
Diagnosis OngoingThis is a Phase 1/2 study evaluating the positron-emitting radiopharmaceutical 18F-mFBG as an imaging agent for quantification of myocardial sympathetic innervation.
Phase: PHASE1, PHASE2 • Sponsor: Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
New iron supplement may be kinder to Kids' stomachs
Disease control CompletedThe objective of the study is to compare the safety and gastrointestinal tolerability of ferric maltol oral suspension and ferrous sulfate oral liquid in children and adolescents aged 2 years to 17 years, and assess the safety and tolerability of ferric maltol oral suspension in …
Phase: PHASE3 • Sponsor: Shield Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can a low FODMAP diet soothe IBS even without lactose issues?
Symptom relief Recruiting nowIrritable bowel syndrome (IBS) is a frequently encountered disorder. According to the Rome IV criteria, it is characterized by abdominal pain associated with a change in stool frequency or con-sistency, or with symptomatic improvement by defecation (Mearin 2016). Associated sympt…
Phase: PHASE3 • Sponsor: Universitair Ziekenhuis Brussel • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Acupuncture and massage may ease cancer treatment side effects, new study suggests
Symptom relief Recruiting nowThe use of complementary and integrative medicine (CIM) among oncology patients is widespread, with a large body of research-based evidence supporting the ability of these therapies to alleviate symptoms related to cancer and its treatment. Organizations such as the American Soci…
Phase: NA • Sponsor: Shaare Zedek Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New scoring tool could predict when ventilator patients can breathe on their own
Diagnosis CompletedPatients on mechanical ventilation (MV) must undergo weaning, an interruption of ventilatory support. Several scores have been developed to predict this outcome, but the failure index in weaning and extubation remains high. The aim of this study is to evaluate the effect of ExPre…
Phase: NA • Sponsor: Universidade do Oeste de Santa Catarina • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC
-
Promising prostate cancer combo study halted early
Disease control TerminatedThe study is being conducted to evaluate the efficacy and safety of SHR3680 plus androgen deprivation therapy (ADT) vs. placebo plus ADT in patients with high-risk localized or locally advanced prostate cancer using pathologic complete response (pCR) rate and metastasis-free surv…
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can ultrasound predict which dialysis access will work?
Diagnosis CompletedHaemodialysis is a renal replacement therapy that can be introduced to patients with end-stage renal disease (ESRD) to help them maintain a good healthy life. The patient's blood is pumped through a dialysis machine to remove excess fluid, salt and waste, then it is pumped back i…
Sponsor: Imperial College London • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
Could a brain booster stop schizophrenia before it starts?
Disease control Recruiting nowPrevious studies found that some NMDA-enhancing agents were able to improve clinical symptoms of patients with schizophrenia. Whether treatment of an NMDA-enhancing agent can benefit the treatment of prodromal schizophrenia deserves study.
Phase: PHASE2 • Sponsor: China Medical University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Free quit-smoking support for heart patients could save lives and money
Disease control OngoingA better understanding of how to incorporate effective smoking cessation measures into clinical practice is requested. In this is prospective, multi-center, randomized, open, blinded end-point (PROBE) trial, we assigned daily smokers hospitalized with an acute cardiac event 1:1 t…
Phase: NA • Sponsor: Vestre Viken Hospital Trust • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New sling study aims to ease bladder leakage in women
Disease control Recruiting nowA post-market study to compare the safety and effectiveness of the Desara® One Single Incision Sling (SIS), when compared to that of an FDA cleared transobturator sling over a period of 36 months.
Phase: NA • Sponsor: Caldera Medical, Inc. • Aim: Disease control
Last updated Jun 26, 2026 19:05 UTC
-
New hip fracture fixation device put to the test against traditional screws
Disease control CompletedThis prospective multicenter cohort study is to compare the post-operative implant failure rate between the patients with femoral neck fracture (AO classification 31-B) using Femoral Neck System (FNS) versus Multiple Cancellous Screws (MCS) at 2-year follow up. The patients are d…
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Brain resilience in bipolar disorder: what protects thinking skills?
Knowledge-focused OngoingBipolar disorder (BD) ïs the fourth leading cause of disability worldwide among young people. Differences in demographic and clinical characteristics between patients do not influence educational achievement and receipt of disability pension, indicating that there are other facto…
Sponsor: St. Olavs Hospital • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Massive study tracks 15,000 people to unravel long COVID mysteries
Knowledge-focused CompletedThis is a combined retrospective and prospective, longitudinal, observational meta-cohort of individuals who will enter the cohort with and without SARS-CoV-2 infection and at varying stages before and after infection. Individuals with and without SARS-CoV-2 infection and with or…
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Double-Drug attack on tough pancreatic cancer shows promise in small trial
Disease control CompletedThe purpose of this research is to determine the benefit of two oral chemotherapy drugs, Vemurafenib and Sorafenib, in individuals with KRAS mutated pancreatic cancer who have progressed on standard chemotherapy.
Phase: PHASE2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a Two-Drug cocktail tame ALS? early trial hints at hope
Disease control CompletedIn Amyotrophic Lateral Sclerosis (ALS), the reduction of regulatory T-lymphocyte (Treg) numbers and suppressive function correlates with rapid disease progression. The investigator completed a phase 1 study of infusions of expanded autologous Tregs in combination with subcutaneou…
Phase: PHASE1 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
One shot to soothe: new injection may replace eye drops after cataract surgery
Disease control CompletedThis is a prospective, real-world study aimed to evaluate the efficacy and safety of Dexycu in treating postoperative inflammation of cataracts.
Phase: PHASE4 • Sponsor: Ocumension Therapeutics (Shanghai) Co., Ltd • Aim: Disease control
Last updated Jun 26, 2026 13:06 UTC
-
New therapy aims to retrain the brain in kids with Seizure-Like episodes
Symptom relief Recruiting nowThe purpose of this study is to assess sense of control and catastrophic symptom expectations as targets for Retraining and Control Therapy (ReACT- an intervention focused on changing behaviors and thoughts) for treatment of pediatric psychogenic non-epileptic seizures (PNES, epi…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 26, 2026 13:21 UTC
-
Pfizer tests new drug cocktail for Hard-to-Treat myeloma
Disease control TerminatedThe purpose of this study is to determine the Recommended Phase 2 Dose and clinical benefit of elranatamab in combination with other anti-cancer therapies in participants with multiple myeloma.
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New pill shows promise for Hard-to-Treat kidney cancer
Disease control TerminatedThe goal of the Phase 1 portion is to identify the maximum tolerated dose (MTD) and/or the recommended doses for expansion (RDEs) of NKT2152. The Phase 2 portion will evaluate the efficacy of NKT2152 in ccRCC.
Phase: PHASE1, PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Phone app aims to stop diet cheats before they happen
Symptom relief OngoingThis project targets dietary lapses (instances of nonadherence to dietary goals), a major cause of poor outcomes during behavioral obesity treatment, which is a recommended first-line intervention for cardiovascular disease. The investigators propose to conduct a micro-randomized…
Phase: NA • Sponsor: The Miriam Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC